Note: Ingredients listed on restricted chemical lists
EC/CAS
206-019-2/288-32-4
Name of the chemical
Imidazol (2015/1221)
Concentration
10 - 20
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
<0,1
General Information
Version
1.3
Revision date
2022-03-11
Product name
Fructan HK Assay Kit (Bottle 1)
1.2.1 Relevant identified uses
Industrial/Professional use spec
Emergency telephone
+353 12861220
Icons in SDS
Company Information
company name
Megazyme
e-mail address of the competent person responsible for the Safety Data Sheet
cs@megazyme.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H360
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May damage fertility or the unborn child. Causes severe skin burns and eye damage. Causes serious eye damage
Hazard pictograms
GHS05 GHS08
Signal word
Danger
Contains
imidazole
Hazard statements
H314 - Causes severe skin burns and eye damage. H360 - May damage fertility or the unborn child.
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, spray, vapours. P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection.
Supplemental label elements
EUH032 - Contact with acids liberates very toxic gas.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin corrosion/irritation, Category 1, Sub-Category 1C H314 Reproductive toxicity, Category 1B H360 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May damage fertility or the unborn child. Causes severe skin burns and eye damage. Causes serious eye damage. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS05 GHS08 Signal word (CLP) : Danger Contains : imidazole Hazard statements (CLP) : H314 - Causes severe skin burns and eye damage. H360 - May damage fertility or the unborn child. Precautionary statements (CLP) : P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, spray, vapours. P264 - Wash hands thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. EUH-statements : EUH032 - Contact with acids liberates very toxic gas. 2.3. Other hazards Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] imidazole CAS-No.: 288-32-4 10 – 20 Acute Tox. 4 (Oral), H302 EC-No.: 206-019-2 Skin Corr. 1C, H314 EC Index-No.: 613-319-00-0 Repr. 1B, H360D MAGNESIUM CHLORIDE CAS-No.: 7786-30-3 1 – 5 Met. Corr. 1, H290 EC-No.: 232-094-6 Acute Tox. 4 (Oral), H302 REACH-no: 01-2119485597- Skin Irrit. 2, H315 19 Eye Dam. 1, H318 sodium azide CAS-No.: 26628-22-8 < 0,1 Acute Tox. 2 (Oral), H300 substance with a Community workplace exposure limit EC-No.: 247-852-1 Aquatic Acute 1, H400 EC Index-No.: 011-004-00-7 Aquatic Chronic 1, H410 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures general : Call a physician immediately. First-aid measures after inhalation : Remove person to fresh air and keep comfortable for breathing. First-aid measures after skin contact : Rinse skin with water/shower. Take off immediately all contaminated clothing. Call a physician immediately. First-aid measures after eye contact : Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a physician immediately. First-aid measures after ingestion : Rinse mouth. Do not induce vomiting. Call a physician immediately. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects after skin contact : Burns. Symptoms/effects after eye contact : Serious damage to eyes. Symptoms/effects after ingestion : Burns. 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : Water spray. Dry powder. Foam. Carbon dioxide. 5.2. Special hazards arising from the substance or mixture Hazardous decomposition products in case of fire : Toxic fumes may be released. 5.3. Advice for firefighters Protection during firefighting : Do not attempt to take action without suitable protective equipment. Self-contained